SYNTHESIS OF 3-HYDROXYESTRA-1,3,5(10)-TRIEN-17-ONE AND 3,17-BETA-DIHYDROXYESTRA-1,3,5(10)-TRIENE 6-ALPHA-N-(EPSILON-BIOTINYL)CAPROAMIDE, TRACER SUBSTANCES FOR DEVELOPING IMMUNOASSAYS FOR ESTRONE AND ESTRADIOL
P. Luppa et al., SYNTHESIS OF 3-HYDROXYESTRA-1,3,5(10)-TRIEN-17-ONE AND 3,17-BETA-DIHYDROXYESTRA-1,3,5(10)-TRIENE 6-ALPHA-N-(EPSILON-BIOTINYL)CAPROAMIDE, TRACER SUBSTANCES FOR DEVELOPING IMMUNOASSAYS FOR ESTRONE AND ESTRADIOL, Bioconjugate chemistry, 5(2), 1994, pp. 167-171
We describe the synthesis of 3-hydroxyestra-1,3,5(10)-trien-17-one 6al
pha-N-(epsilon-biotinyl)caproamide and 3,17beta-dihydroxyestra-1,3,5(1
0)-triene 6alpha-N-(epsilon-biotinyl)caproamide from 3-hydroxyestra-1,
3,5(10)-trien-17-one and 3,17 beta-dihydroxyestra-1,3,5(10)-triene, vi
a the 6-keto estrogenic derivatives. The reductive amination of these
compounds is an effective step toward an epimeric mixture of the respe
ctive amines, which are easily biotinylated by use of N-(epsilon-bioti
nylcaproyl)-N-hydroxysuccinimide ester. The 6alpha-epimers could be is
olated from the alpha/beta-composition by application of isocratic HPL
C, and overall yields were about 20% for the epimeric end products. Th
e structures of the stereoisomers could clearly be assigned through H-
1 NMR studies. The ratios of the respective isomers obtained from the
reductive amination were found to be 3(alpha):2(beta). The biotinylate
d estrogens can be used as tracers in a novel immunoassay concept for
the determination of these analytes in human serum. Ring position 6 wa
s selected for derivatization because of its distance from the functio
nalized positions 3 and 17 and, therefore, of a negligible alteration
of the tracer's structure in comparison to underivatized estrone or es
tradiol.